companydata.dkRenescience A/S: Financial statements 2024
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 10,836,000 and a net result of DKK -23,904,000 compared with DKK -194,649,000 the year before. That is an increase of 4% compared with the year before. The profit margin was -220.6%. Equity amounted to DKK 7,407,000. The solvency ratio was 50.8%. The company had 1,000 employees in the financial year.
- Revenue
- 10,836,000 kr.
- Gross Profit
- -15,360,000 kr.
- Profit/Loss
- -23,904,000 kr.
- Equity
- 7,407,000 kr.
- Total Assets
- 14,580,000 kr.
- Employees
- 1,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 10.8 mio. | -15.4 mio. | -23.9 mio. | 7.4 mio. | 1000 |
| 2023 | 10.4 mio. | -13.5 mio. | -194.6 mio. | -11.7 mio. | 0 |
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
| 2020 | 1.7 mio. | -16.6 mio. | -13.5 mio. | 31.1 mio. | - |
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of December 20, 2024, Lars Holm Lerke-Møller has joined the board of directors of Renescience A/S.
As of December 20, 2024, Hanne Risbjerg Sørensen has left the board of directors of Renescience A/S.
As of December 20, 2024, Lars Holm Lerke-Møller is registered as director of Renescience A/S.
As of December 20, 2024, Hanne Risbjerg Sørensen has stepped down as director of Renescience A/S.
Renescience A/S has published its annual report for 2023. Revenue came to DKK 10,419,000, and the net result was DKK -194,649,000.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.